Hyperthyroidism during pregnancy is uncommon. Nonetheless, prompt identification and
adequate management of hyperthyroidism in a pregnant woman is essential, because …

Autoimmune thyroid diseases (AITDs) include a wide spectrum of thyroid diseases affecting
more commonly women than men. The most frequent forms are Graves' Disease (GD) and …

Abstract Background Graves' hyperthyroidism affects 0.2% of pregnant women. Establishing
the correct diagnosis and effectively managing Graves' hyperthyroidism in pregnancy …

Objective Maternal hyperthyroidism and antithyroid medications have been associated with
adverse pregnancy and perinatal outcomes. This nationwide register‐based study …

Graves' disease is the most common cause of hyperthyroidism in iodine-replete areas.
Although progress has been made in our understanding of the pathogenesis of the disease …

Background Hyperthyroidism affects about 0.2%-2.7% of all pregnancies, and is generally
treated with propylthiouracil (PTU). However, previous studies about the effects of …

Objective The aim of this study was to determine the effect of exposure to different antithyroid
drugs during pregnancy on the incidence of neonatal congenital malformations. Methods A …

Antithyroid drugs (ATDs) are preferred for the treatment of hyperthyroidism caused by
Graves' disease in pregnant women. The drugs have been a recognized treatment for …

Context Antithyroid drug (ATD) therapy in early pregnancy is associated with birth defects,
but more data are needed to substantiate the risk associated with different types of ATD …

Abstract Objective Antithyroid drugs (ATDs) may have teratogenic effects, but more evidence
is needed on the risk and types of birth defects after the use of methimazole (MMI) and …